Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial

✍ Scribed by Claus G. Roehrborn; Jack Barkin; Paul Siami; Andrea Tubaro; Timothy H. Wilson; Betsy B. Morrill; R. Paul Gagnier

• Book ID: 110923617
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 430 KB
• Volume: 107
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2011.10124.x